Transaction · 0001193125-26-382277
AXSMAxsome Therapeutics, Inc.
Jacobson Mark L.
Jacobson Mark L., COO, reported an open-market or private sale at Axsome Therapeutics, Inc. involving 10000.000000 shares for an estimated $2086500.00. Reported holdings after the transaction were 0.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Open-market sellSEC transaction code SCOO
- Trade date
- Sep 03, 2026
- Filing date
- Sep 03, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 10,000 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
AXSM price since this filing
Daily closing prices, with the filing date and available return windowsAXSM · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +3.3%1w ago +0.0%1d ago +0.0%
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001193125-26-382277 Common Stock
- Transaction date
- Sep 03, 2026 Filed Sep 03, 2026, 11:09 PM · 0d delay
- Shares
- 10,000 sh $208.65 per share
- Estimated value
- -$2.08M Computed from shares × price
- Holdings after
- 0 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Sale 10b5-1 Detected
Filing-only score
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
Neutral filing signal
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 0
Filing reported within two business days of the transaction. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
Chief Operating Officer
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
Represents an exercise of stock options which were held for 7 years and exercised prior to the 10 year expiration date of such options.
- F2
Such transaction was pursuant to a pre-approved 10b5-1 plan.
- F3
Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
- F4
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $206.41 and $210.34.
Related transactions
Same SEC filing0 other transactions
Recent company activity
AXSM0 recent txs